Cargando…

Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer

BACKGROUND: We previously developed an immunotherapy treatment utilizing a cancer vaccine reagent KIF20A-66 in order to treat pancreatic cancer. KIF20A-66 is HLA-A24-restricted epitope peptide derived from KIF20A, a member of kinesin super family protein 20A that is significantly transactivated in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asahara, Shingo, Takeda, Kazuyoshi, Yamao, Kenji, Maguchi, Hiroyuki, Yamaue, Hiroki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225607/ https://www.ncbi.nlm.nih.gov/pubmed/24237633 http://dx.doi.org/10.1186/1479-5876-11-291

Ejemplares similares

Identification of HLA-A24-Restricted Novel T Cell Epitope Peptides Derived from P-Cadherin and Kinesin Family Member 20A
por: Osawa, Ryuji, et al.
Publicado: (2012)

Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2018)

Identification of an HLA-A2-Restricted Epitope Peptide Derived from Hypoxia-Inducible Protein 2 (HIG2)
por: Yoshimura, Sachiko, et al.
Publicado: (2014)

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53
por: Umano, Y, et al.
Publicado: (2001)

Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer
por: Imai, K, et al.
Publicado: (2011)

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer
por: Suzuki, Nobuaki, et al.
Publicado: (2014)

Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC Study
por: Yamaue, Hiroki, et al.
Publicado: (2015)

Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas
por: Tanaka, H, et al.
Publicado: (2001)

KIF24 depletion induces clustering of supernumerary centrosomes in PDAC cells
por: Mashima, Yu, et al.
Publicado: (2022)

Prognostic Significance of KIF11 and KIF14 Expression in Pancreatic Adenocarcinoma
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2021)

Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer
por: SAWADA, YU, et al.
Publicado: (2014)

History of pancreatic surgery in Japan: Respect to the Japanese pioneers of pancreatic surgery
por: Yamaue, Hiroki
Publicado: (2020)

Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA‐A24‐positive pancreatic adenocarcinoma
por: Shima, Hiroaki, et al.
Publicado: (2019)

Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides
por: Pedersen, Sara Ram, et al.
Publicado: (2016)

KIF20A-Mediated RNA Granule Transport System Promotes the Invasiveness of Pancreatic Cancer Cells()
por: Taniuchi, Keisuke, et al.
Publicado: (2014)

KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer
por: Chen, Jing, et al.
Publicado: (2021)

Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spectrometry
por: Fujiwara, Kenji, et al.
Publicado: (2022)

Releasing the concept of HLA‐allele specific peptide anchors in viral infections: A non‐canonical naturally presented human cytomegalovirus‐derived HLA‐A*24:02 restricted peptide drives exquisite immunogenicity
por: Pump, Wiebke C., et al.
Publicado: (2019)

Prognostic significance of KIF2A and KIF20A expression in human cancer: A systematic review and meta-analysis
por: Li, Xing, et al.
Publicado: (2019)

HLA autoimmune risk alleles restrict the hypervariable region of T cell receptors
por: Ishigaki, Kazuyoshi, et al.
Publicado: (2022)

HLA-F Allele-Specific Peptide Restriction Represents an Exceptional Proteomic Footprint
por: Hò, Gia-Gia T., et al.
Publicado: (2019)

Upregulation of KIF20A correlates with poor prognosis in gastric cancer
por: Sheng, Yi, et al.
Publicado: (2018)

The SUN2-nesprin-2 LINC complex and KIF20A function in the Golgi dispersal
por: Hieda, Miki, et al.
Publicado: (2021)

Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies
por: Matsushita, Maiko, et al.
Publicado: (2016)

Rapid Multiplex Genotyping of 20 HLA-A(*)02:01 Restricted Minor Histocompatibility Antigens
por: Romaniuk, Dmitrii S., et al.
Publicado: (2019)

Peptide Modification Diminishes HLA Class II-restricted CD4(+) T Cell Recognition of Prostate Cancer Cells
por: Doonan, Bently P., et al.
Publicado: (2022)

KIF20A Regulates Porcine Oocyte Maturation and Early Embryo Development
por: Zhang, Yu, et al.
Publicado: (2014)

Positive expression of KIF20A indicates poor prognosis of glioma patients
por: Duan, Jia, et al.
Publicado: (2016)

USP7 Regulates Cytokinesis through FBXO38 and KIF20B
por: Georges, Anna, et al.
Publicado: (2019)

Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer
por: Jin, Zheng, et al.
Publicado: (2023)

HLA-A24-restricted HTLV-I-specific CTL response reduces the HTLV-I proviral load but the HLA increases the risk of HAM/TSP
por: Kubota, Ryuji, et al.
Publicado: (2011)

Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations
por: Iiizumi, Susumu, et al.
Publicado: (2019)

Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle
por: Kim, Sehyun, et al.
Publicado: (2015)

A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer
por: Sundar, Raghav, et al.
Publicado: (2018)

Apparent lack of MHC restriction in binding of class I HLA molecules to solid-phase peptides
Publicado: (1990)

Synthetic peptides as antigens and competitors in recognition by H-2- restricted cytolytic T cells specific for HLA
Publicado: (1988)

FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
por: Yu, Hongbo, et al.
Publicado: (2020)

Nucleotide-free structures of KIF20A illuminate atypical mechanochemistry in this kinesin-6
por: Ranaivoson, Fanomezana Moutse, et al.
Publicado: (2023)

A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy
por: Katsuda, Masahiro, et al.
Publicado: (2019)

HLA-B7–Restricted Islet Epitopes Are Differentially Recognized in Type 1 Diabetic Children and Adults and Form Weak Peptide-HLA Complexes
por: Scotto, Matthieu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_em5419n2p7jichk40iu1a3e824